コロナワクチン情報

臨床研究・
クリニカルリサーチ

論文・著書

著書・論文

【著書・論文(英語)】

  1. Impact of Chronic Kidney Disease on the Associations of Cardiovascular Biomarkers With Adverse Outcomes in Patients With Suspected or Known Coronary Artery Disease: The EXCEED-J Study.Wada H, Shinozaki T, Suzuki M, Sakagami S, Ajiro Y, Funada J, Matsuda M, Shimizu M, Takenaka T, Morita Y, Yonezawa K, Matsubara H, Ono Y, Nakamura T, Fujimoto K, Ninomiya A, Kato T, Unoki T, Takagi D, Wada K, Wada M, Iguchi M, Yamakage H, Kusakabe T, Yasoda A, Shimatsu A, Kotani K, Satoh-Asahara N, Abe M, Akao M, Hasegawa K; EXCEED‐J Study Investigators.J Am Heart Assoc. 2022 Feb;11(3):e023464.
  2. Funamoto M, Sunagawa Y, Katanasaka Y, Kato T, Funada J, Ajiro Y, Komiyama M, Akao M, Yasoda A, Yamakage H, Satoh-Asahara N, Wada H, Ikeda Y, Morimoto T, Hasegawa K.Effects of high-absorption curcumin for the prevention of hypertensive heart disease: a double-blind, placebo-controlled, randomized clinical study. Eur Heart J Open. 2022 ;2(5): oeac057.
  3. Masahiro Watanabe, Yoichi Ajiro, Shun Hasegawa, Kazuyuki Hamada, Kei Tsukamoto, Takashi Saito, Ryosuke Furuya , Tatsuji Komatsu, Fumiaki Mori.Clinical factors associated with successful venoarterial extracorporeal membrane oxygenation weaning: A single-center retrospective cohort study. Crit Care Shock (2023) 26:115-124.
  4. Effects of a Pharmacist-Led Educational Interventional Program on Electronic Monitoring-assessed Adherence to Direct Oral Anticoagulants: A Randomized, Controlled Trial in Patients with Nonvalvular Atrial Fibrillation.Shiga T, Kimura T, Fukushima N, Yoshiyama Y, Iwade K, Mori F, Ajiro Y, Haruta S, Yamada Y, Sawada E, Hagiwara N; SMAAP-AF Investigators.Clin Ther. 2022 Nov;44(11):1494-1505. doi: 10.1016/j.clinthera.2022.09.011. Epub 2022 Oct 13.PMID: 36244853 Free article. Clinical Trial.
  5. Electronic monitoring of adherence to once-daily and twice-daily direct oral anticoagulants in patients with atrial fibrillation: Baseline data from the SMAAP-AF trial.Shiga T, Kimura T, Fukushima N, Yoshiyama Y, Iwade K, Mori F, Ajiro Y, Haruta S, Yamada Y, Sawada E, Hagiwara N; SMAAP‐AF investigators.J Arrhythm. 2021 Mar 30;37(3):616-625. doi: 10.1002/joa3.12532. eCollection 2021 Jun.PMID: 34141014 Free PMC article.
  6. Soluble vascular endothelial growth factor receptor 2 and prognosis in patients with chronic heart failure.Iguchi M, Wada H, Shinozaki T, Suzuki M, Ajiro Y, Matsuda M, Koike A, Koizumi T, Shimizu M, Ono Y, Takenaka T, Sakagami S, Morita Y, Fujimoto K, Yonezawa K, Yoshida K, Ninomiya A, Nakamura T, Funada J, Kajikawa Y, Oishi Y, Kato T, Kotani K, Abe M, Akao M, Hasegawa K; PREHOSP-CHF Study Investigators.ESC Heart Fail. 2021 Oct;8(5):4187-4198. doi: 10.1002/ehf2.13555. Epub 2021 Aug 13.PMID: 34387398 Free PMC article.
  7. Wada H, Suzuki M, Matsuda M, Ajiro Y, Shinozaki T, Sakagami S, Yonezawa K, Shimizu M, Funada J, Takenaka T, Morita Y, Nakamura T, Fujimoto K, Matsubara H, Kato T, Unoki T, Takagi D, Wada K, Wada M, Iguchi M, Masunaga N, Ishii M, Yamakage H, Kusakabe T, Yasoda A,Shimatsu A, Kotani K, Satoh-Asahara N, Abe M, Akao M, Hasegawa K; ANOX Study Investigators. Distinct Characteristics of VEGF-D and VEGF-C to Predict Mortality in Patients With Suspected or Known Coronary Artery Disease. J Am Heart Assoc. 2020 May 5;9(9):e015761.
  8. Wada H, Suzuki M, Matsuda M, Ajiro Y, Shinozaki T, Sakagami S, Yonezawa K, Shimizu M, Funada J, Iguchi M, Masunaga N, Ishii M, Yamakage H, Kusakabe T, Yasoda A, Shimatsu A, Kotani K, Satoh-Asahara N, Abe M, Akao M, Hasegawa K; ANOX Study Investigators. Impact of Smoking Status on Growth Differentiation Factor 15 and Mortality in Patients With Suspected or Known Coronary Artery Disease: The ANOX Study. J Am Heart Assoc. 2020 Nov 17;9(22):e018217.
  9. Koike T, Mori F, Maeda R, Kobayashi K, Sakai M, Oyabu K, Matsui Y, Yoshikawa M, Sugiyama K, Ajiro Y, Iwade K. Semi-urgent pulmonary vein isolation using cryoballoon for haemodynamically unstable atrial fibrillation storm in a patient with low cardiac output syndrome: a case report. BMC Cardiovasc Disord. 2020 Sep 11;20(1):413.
  10. Ajiro Y, Nino H, Ueda T, Bonkohara Y., Granulocyte-colony stimulating factor– and interleukin-1β–positive cardiac myxoma accompanying neutrophilic dermatosis. JTCVS Techniques 2020; 1: 69-71.
  11. Ajiro Y, Sekiguchi H, Akita T, Fukunaga H, Iwade K. Estimation of OptiVol alert for identifying heart failure in conventional bradyarrhythmia pacing patients with preserved left ventricular function: A multicenter prospective cohort study (OptiVol study). Philipp J Cardiol 2019;47(1):10-15.
  12. Nomura K, Ajiro Y (equal contribution to first author), Nakano S, Matsushima M, Yamaguchi Y, Hatakeyama N, Ohata M, Sakuma M, Nonaka T, Harii H, Utsumi M, Sakamoto K, Iwade K, Kuninaka K. Characteristics of mitral valve leaflet length in patients with pectus excavatum: A single center cross-sectional study. PLoS One. 2019 Feb 11;14(2):e0212165.
  13. Wada H, Suzuki M, Matsuda M, Ajiro Y, Shinozaki T, Sakagami S, Yonezawa K, Shimizu M, Funada J, Takenaka T, Morita Y, Nakamura T, Fujimoto K, Matsubara H, Kato T, Unoki T, Takagi D, Ura S, Wada K, Iguchi M, Masunaga N, Ishii M, Yamakage H, Shimatsu A, Kotani K, Satoh-Asahara N, Abe M, Akao M, Hasegawa K; ANOX Study Investigators. VEGF-C and Mortality in Patients With Suspected or Known Coronary Artery Disease. J Am Heart Assoc. 2018 Nov 6;7(21):e010355. doi: 10.1161/JAHA.118.010355.
  14. Sekiguchi H, Ajiro Y, Uchida Y, Jujo K, Iwade K, Tanaka N, Shimamoto K, Tsurumi Y, Kawana M, Hagiwara N. Contrast-Induced Nephropathy and Oxygen Pretreatment in Patients With Impaired Renal Function. Kidney Int Rep. 2017 Aug 12;3(1):65-72. doi: 10.1016/j.ekir.2017.08.002. eCollection 2018 Jan
  15. Yazaki K, Ajiro Y, Shimizu K, Mori F, Yagihara N, Sato A, Takahashi T, Iwade K., Ventricular fibrillation due to early repolarization syndrome in the wake of hypothermia due to fulminant acute disseminated encephalomyelitis. Circ J 2017 Sep 20. doi: 10.1253/circj.CJ-17-0748
  16. Yazaki K, Ajiro Y, Mori F, Watanabe M, Tsukamoto K, Mizobuchi K, Saito T, Iwade K., Multiple focal and macroreentrant left atrial tachycardias originating from a spontaneous scar at the contiguous aorta-left atrium area in a patient with hypertrophic cardiomyopathy: A case report. BMC Cardiovascular Disorders 2017; 17(1):29. doi:10.1186/s12872-016-0448-3.
  17. Yazaki K, Ajiro Y, Hasegawa S, Watanabe M, Tsukamoto K, Mizobuchi K, Saito T, Mori F, Iwade K., Myopotential oversensing notified by Lead Integrity Alert in a patient with implantable cardioverter defibrillator with a dedicated bipolar epicardial sensing lead. Clin Case Rep. 2016; 4(12):1091-1095.
  18. Ajiro Y, Mori F, Iwade K. Abrupt disruption of remote monitoring transmission as an indicator of safe backup mode. Europace (2016): doi:10.1093/europace/euw203.
  19. Ajiro Y., Shiga T., Shoda M., Hagiwara N., Surface electromyography of myopotential oversensing provoked by simultaneous straining and leftward twisting in a patient with an implantable cardioverter defibrillator. Heart Vessels. 2016; 32(3):364-368. doi: 10.1007/s00380-016-0888-9.
  20. Morita S, Ajiro Y, Uchida Y, Iwade K.：Dabigatran for left atrial thrombus. Eur Heart J. 2013 Sep;34(35):2745. Epub 2013 May 22.
  21. Sekiguchi H, Ajiro Y, Uchida Y et al.：Oxygen pre-conditioning prevents contrast-induced nephropathy (OPtion CIN Study). J Am Coll Cardiol. 2013 Jul 9;62(2):162-3. Epub 2013 May 1.
  22. Ajiro Y, Saegusa N, Giles WR, Stafforini DM, Spitzer KW：Platelet Activating Factor Stimulates Sodium-Hydrogen Exchange in Ventricular Myocytes. Am J Physiol Heart Circ Physiol. 2011 Dec; 301(6):H2395-401. Epub 2011 Sep 23.
  23. Watanabe E, Matsuda N, Shiga T, Kajimoto K, Ajiro Y, Kawarai H, Kasanuki H, Kawana M：Significance of 8-hydroxy-2′-deoxyguanosine levels in patients with idiopathic dilated cardiomyopathy.　J Card Fail. 2006 Sep;12(7):527-32.
  24. Ajiro Y, Hagiwara N, Kasanuki H.：Assessment of markers for identifying patients at risk for life-threatening arrhythmic events in Brugada syndrome. J Cardiovasc Electrophysiol. 2005 Jan;16(1):45-51.
  25. Yamada Y, Ajiro Y, Shoda M, Kawai A, Hagiwara N, Kurosawa H, Kasanuki H.：Video-assisted thoracoscopy to treat atrial tachycardia arising from left atrial appendage. J Cardiovasc Electrophysiol. 2006 Aug;17(8):895-8.
  26. Ajiro Y, Hagiwara N, Katsube Y, Sperelakis N, Kasanuki H.：Levosimendan increases L-type Ca(2+) current via phosphodiesterase-3 inhibition in human cardiac myocytes. Eur J Pharmacol. 2002 Jan 18;435(1):27-33.【著書・論文(日本語)】
  27. 森由華, 長谷川瞬, 網代洋一, 森文章, 前田遼造, 椙山恒, 齋藤貴士, 八木原伸江, 佐藤光希, 岩出和徳, 古谷良輔. 心室細動蘇生後低体温療法中に出現したBrugada型心電図を契機にBrugada症候群と診断した1例. 心臓2020; 52(5): 548-553.
  28. 網代洋一, 鈴木大輔, 西村祥一, 望月聡之, 深瀬史江, 塩田志乃恵, 菊地龍明, 宇治原誠：国立病院機構横浜医療センターにおける中心静脈カテーテル登録医制度の導入と評価. 日本医療マネジメント学会雑誌2018; 18(4): 217-222.
  29. 矢崎恭一郎, 森文章, 網代洋一, 渡邉真広, 塚本圭, 齋藤貴士, 溝渕景子, 岩出和徳: 反復性運動後失神の原因と考えられる左室流出路狭窄を, イソプロテレノール負荷左室 – 大動脈同時圧測定で証明しえた潜在性閉塞型S字状中隔の1例: 心臓2016; 48(9): 1043-1048.
  30. 服部英敏、清水邦彦、森田彩恵、逸見隆太、内田吉枝、網代洋一、森文章、小林康徳、岩出和徳、田中直秀：大動脈内バルーンパンピングを必要としてトラスツマブによると考えられる心不全の1例：心臓2014；46(11)：1470-1475.
  31. 大木摩希子, 庄田守男, 谷崎剛平, 河原井浩孝, 網代洋一, 佐藤高栄, 高橋一浩, 真中哲之, 江島浩一郎, 萩原誠久, 笠貫宏：Pilsicainide静注により持続性単形性心室頻拍が誘発されアブレーションを行った1例：臨床心臓電気生理 2006；29：241-248.
  32. 萩原誠久, 網代洋一, 笠貫宏.【内科疾患の診断基準病型分類・重症度】　診断メモ　Brugada症候群. 内科(0022-1961)95巻6号 Page1362-1363(2005.06).
  33. 網代洋一, 笠貫宏：冠動脈疾患と植込み型除細動器. 新心臓病プラクテイス5, 冠動脈疾患を見るⅡ.　文光堂 2005年: Page 100-102.
  34. 網代洋一, 萩原誠久, 笠貫宏: 【内科疾患の診断基準病型分類・重症度】 V.循環器, 心室頻拍の診断基準・病型分類・重症度. 臨床雑誌｢内科｣第95巻　第6号（2005年6月増大号）: Page 1321-1328.
  35. 江島浩一郎, 庄田守男, 谷崎剛平, 真中哲之, 佐藤高栄, 網代洋一, 河原井浩孝, 高橋一浩, 萩原誠久, 笠貫宏：慢性心房細動症例に対する生理的ペースメーカ植え込みの経験　Electroanatomical mappingによる残存心房筋の評価に基づいて：心臓2005；37(Suppl.4)：29-35.
  36. 佐藤高栄, 庄田守男, 谷崎剛平, 河原井浩孝, 網代洋一, 高橋一浩, 真中哲之, 江島浩一郎, 萩原誠久, 笠貫宏：左房後壁で遅伝導路アブレーションに成功した稀有型房室結節リエントリー性頻拍の1例：臨床心臓電気生理2005；28：129-138.
  37. 萩原誠久, 梶本克也, 網代洋一, 弓野大, 笠貫宏：不整脈源性右室心筋症. 最新医学2005; 60(10): 2273-2279.
  38. 真中哲之, 庄田守男, 谷崎剛平, 網代洋一, 河原井浩孝, 佐藤高栄, 原田明子, 古賀祥一, 山田雄一郎, 梶本克也, 萩原誠久, 笠貫宏：機能的右室の心筋障害を伴うEbstein奇形に合併したリエントリーを機序とした持続性単形性心室頻拍の1例：心臓2004；36（Suppl.4）：108-115.
  39. 藤森完一, 庄田守男, 谷崎剛平, 河原井浩孝, 網代洋一, 原田明子, 小田川幸成, 井上完起, 西本正興, 芹沢直紀, 松田直樹, 萩原誠久, 笠貫宏：金属アレルギーが疑われた症例に対するICD植込み経験：心臓 2003；35（Suppl.4）：150-154.
  40. 河原井浩孝, 庄田守男, 芹澤直紀, 小田川幸成, 金井佐恵子, 原田明子, 佐藤明, 桶谷直也, 上野一弘, 真中哲之, 網代洋一, 遠田賢治, 谷崎剛平, 杉浦亮, 萩原誠久, 笠貫宏：Disorganized Reentryを機序とする心房頻拍に対するカテーテルアブレーションの1例：臨床心臓電気生理2003；26：59-66.
  41. 萩原誠久, 網代洋一, 長崎陽子, 藤森完一, 谷崎剛平, 梶本克也, 松田直樹, 庄田守男,笠貫宏：Brugada症候群のリスク評価.心電図 2003;23(suppl-4): 29-32.
  42. 萩原誠久, 網代洋一, 長崎陽子, 笠貫宏：Brugada症候群. 心電図2002; 19(12): 2049-2051.
  43. 原田明子, 庄田守男, 芹澤直紀, 小田川幸成, 金井佐恵子, 伊藤大樹, 真中哲之, 桶谷直也, 上野一弘, 網代洋一, 遠田賢治, 河原井浩孝, 谷崎剛平, 杉浦亮, 萩原誠久, 笠貫宏：Wenckebach型exit blockを認めたマイクロリエントリー性心房頻拍の1例：心臓2002；34(Suppl.4)：8-13.
  44. 萩原誠久, 関明子, 長崎陽子, 網代洋一, 笠貫宏：ヒト心房筋イオン電流の特徴と抗不整脈薬の作用.心電図2002;22(suppl-3): 3-11.
  45. 萩原誠久, 関明子, 上勢敬一郎, 網代洋一, 笠貫宏：各種動物における心房筋細胞イオンチャネル―Kチャネルを中心に―.心電図1999;19(suppl-1): 53-56.
  46. 大西哲, 笠貫宏, 庄田守男, 松田直樹, 網代洋一, 川城直美, 細田瑳一.　Overdrive suppressionによるSSSの分類とその意義：心電図1996；16（4）：332-339.
アクセス コロナワクチン03-5876-3838 その他お問い合わせ03-3607-2583